The Global Medical Animation Market, by Type (2D, 3D, 4D and Flash Animation), by Therapeutic Area (Oncology, Plastic Surgery, Cardiology, Dental and Others), by Application (Patient Education, Medical Device/ Drug Formula Simulation, Molecular/ Cellular Animation, Emergency Care Education, Surgical Training, Forensic Reconstruction) and By End User (Pharmaceutical and Medical Device Manufacturers, Hospitals and Clinics, Research Laboratories and others) was valued at US$ 176.6 million in 2017 and is projected to exhibit a CAGR of 19.3% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights.
Medical animation helps a doctor to explain to the patients how things work inside the human body, and how the suggested procedure would help that patient to treat the cause of ailment. This also helps the doctors to reduce the patients’ anxiety levels and address their fears. The need to present information in a visually appealing and informative format for better understanding the product or procedure to patients. This in turn will create a new and exciting battleground for companies in the medical animation market. 3D animation is one of the adopted medical animation type by companies that enable better sense and depth of procedure or a particular product which helps to capture the interest and leave a positive impression or motivate people to make a purchase. Rising prevalence of cancer followed by rising R&D concerning new drug development that creates demand for animated studies explaining drug mechanisms which will propel the industry growth over the forecast period.
Request Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1031
Browse 29 Market Data Tables and 33 Figures spread through 175 Pages and in-depth TOC on “Medical Animation Market, by Type (2D, 3D, 4D and Flash Animation), by Therapeutic Area (Oncology, Plastic Surgery, Cardiology, Dental and Others), by Application (Patient Education, Medical Device/ Drug Formula Simulation, Molecular/ Cellular Animation, Emergency Care Education, Surgical Training, Forensic Reconstruction) and By End User (Pharmaceutical and Medical Device Manufacturers, Hospitals and Clinics, Research Laboratories and others) – Global Forecast to 2025″
Promotion through field representatives is the most dependable strategy followed by pharmaceutical and biotechnology companies. However, communication through this channel is not effective as desired, especially for highly potential novel molecules. This can be effectively addressed by medical animation as it allows customer engagement and visual understanding of the product. Medical animation was initially a niche area within the animation and graphics industry. The medical animation market is developing, due to interest of various pharmaceuticals manufacturers, medical organizations, medical device manufacturers, and life sciences research firms. For instance, Amgen, Pfizer, Inc. and Salix Pharmaceuticals are developing a drug delivery animation for patient education.
As the medical and pharmaceutical products are getting more complicated, the demand for medical animation is increasing more frequently to explain the function of the products clearly and to emphasize specific values of individual product by animating their complexity and uniqueness. For instance, Random42 scientific communication has worked with 23 top pharmaceutical companies including Abbott, Allergan, Pfizer, Merck, and Janssen for creating medical animation, where the company has also created digital assets for over 550 global pharmaceutical products. Random42 Scientific Communication also launched a new medical animation showreel in March 2017, as the showreel is the selection of Random42’s best medical animation work that were produced over last few year, which is expected to attract the pharmaceutical or medical device manufacturers to the medical animation. The Pediatric Brain Tumor Foundation, with the support of Rubin Postaer and Associates (RPA), a Californian advertising agency, is working to combat childhood cancer with their newly established Imaginary Friend Society, which consists of 20 animated short films that provide comforting and empowering narratives for the children undergoing cancer treatment, in turn supporting the growth of medical animation.
Key players in the market are engaged in adopting various medical animation technologies to promote their product brand which in turn will boost their overall sales. For instance, VAYA Pharma’s product Vayarin, a non-drug prescription medical food for the dietary management of ADHD in children, had a niche target audience. In order to attract the target population VAYA Pharma in year 2016, created an animation to explain its prescription medical food, Vayarin, which boosted its product adoption significantly. Such constructive use of the technology can tremendously favor the growth of medical animation market.
Request a Customization: https://www.coherentmarketinsights.com/insight/request-customization/1031
Key Takeaways of the Medical Animation Market:
The global medical animation market is expected to exhibit a CAGR of 19.3% over the forecast period (2017–2025). This is attributed to adoption of competitive strategies by companies such as new product development, merger & acquisitions and technology upgradation. Many manufacturers such as Pfizer Inc., Beckton and Dickinson Company works in collaboration with medical animated companies for their product demonstrations and brand awareness.
Among product types, 3D segment is expected to account for the largest share in the global medical animation market over the forecast period. This is attributed to extensively use in forensic science for visualizing crime scenes or accident.
Explaining drug mechanism of action in pharmaceutical companies and promotion of healthcare products, offering surgical training to the doctors, educating patients about their treatment against specific diseases are among the top applications of medical animation.
Among Therapeutic area, oncology segment propel the growth owing to rising prevalence of cancer followed by greater penetration in research and academic institutes.
Advent of biological illustration in explaining drug mechanism of action in pharmaceutical companies is among the top end user of medical animation
Some of the major players in the global medical animation market are Infuse Medical, Hybrid Medical Animation, Inc., Ghost Productions, Inc., Scientific Animations, Inc., INVIVO Communications, Inc., Random42 Scientific Communication, Radius Digital Science, Nucleus Medical Media, Inc., AXS Studio, Inc., Trinsic Medical Animation, LLC., and Medmovie Inc.